Masimo Corporation (MASI) : The total negative money flow of $1.81 million on Wednesday indicates selling on strength. The inflow of money on upticks was $1.23 million, compared to $3.04 million outflow on downticks, which confirms distribution in the stock. The up to down ratio was 0.4. The negative money flow of $2.29 million in block trades reveals that the informed traders sold the stock on every bit of price strength.The transaction value of block trade on downtick was $2.29 million. The price action in the Masimo Corporation (MASI) stock suggests that both the bulls and the bears were in equilibrium. The stock traded at $53.69 with a gain of $0.78 , a change of 1.47% over the previous days close. The stock registered 2.33% for the week.
Also, Roth Capital maintains its view on Masimo Corporation (NASDAQ:MASI) according to the research report released by the firm to its investors. The shares have now been rated Buy by the stock experts at the ratings house. Roth Capital raises the price target from $40 per share to $50 per share on Masimo Corporation. The rating by the firm was issued on May 5, 2016.
Masimo Corporation (NASDAQ:MASI): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $53.17 and $52.98 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $53.97. The buying momentum continued till the end and the stock did not give up its gains. It closed at $52.98, notching a gain of 0.13% for the day. The total traded volume was 419,039 . The stock had closed at $52.91 on the previous day.
The stock has recorded a 20-day Moving Average of 1.84% and the 50-Day Moving Average is 4.88%. In a related news, The Securities and Exchange Commission has divulged that Van Ramshorst David J, Officer (Chief Accounting Officer) of MASIMO CORP, had unloaded 5,000 shares at an average price of $52.5 in a transaction dated on June 30, 2016. The total value of the transaction was worth $262,500.
Masimo Corporation is a global medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Companys core business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include non-invasive optical blood constituent monitoring, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and optical gas monitoring. In addition, the Company offers Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor and the Radius-7 wearable wireless patient monitor. The Company also has the Patient SafetyNet remote patient surveillance monitoring system, which allows up to 80 patients to be monitored simultaneously through a central station or remotely by care providers through their pagers or smart phones.